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Background: Non-specific chronic low back pain (NSCLBP) is one of the most common musculoskeletal disorders
around the world including Iran. One of the most widely used modalities in the field of physiotherapy is
therapeutic ultrasound (US). Despite its common use, there is still inconclusive evidence to support its effectiveness
in patients with NSCLBP. The objective of this study was to evaluate the effect of continuous US compared with
placebo US additional to exercise therapy for patients with NSCLBP.
Methods: In this single blind placebo controlled study, 50 patients with NSCLBP were randomized into two
treatment groups: 1) continuous US (1 MHz &1.5 W/cm2) plus exercise 2) placebo US plus exercise. Patients received
treatments for 4 weeks, 10 treatment sessions, 3 times per week, every other day. Treatment effects were assessed
in terms of primary outcome measures: 1) functional disability, measured by Functional Rating Index, and 2) global
pain, measured by a visual analog scale. Secondary outcome measures were lumbar flexion and extension range of
motion (ROM), endurance time and rate of decline in median frequency of electromyography spectrum during a
Biering Sorensen test. All outcome variables were measured before, after treatment, and after one-month follow-up.
An intention to treat analysis was performed. Main effects of Time and Group as well as their interaction effect on
outcome measures were investigated using repeated measure ANOVA.
Results: Analysis showed that both groups had improved regarding function (FRI) and global pain (VAS) (P < .001).
Lumbar ROM as well as holding time during the Sorensen test and median frequency slope of all measured
paravertebral muscles did not change significantly in either group (P > .05). Improvement in function and lumbar
ROM as well as endurance time were significantly greater in the group receiving continuous US (P < .05).
Conclusions: The study showed that adding continuous US to a semi supervised exercise program significantly
improved function, lumbar ROM and endurance time. Further studies including a third group of only exercise and
no US can establish the possible effects of placebo US.
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Low back pain (LBP) is a major cause of morbidity
in high, middle and low-income countries and affects
80–85% of people over their lifetime [1]. LBP is a com-
mon health and socioeconomic problem in Iran. In a
cross-sectional study in one of the largest car-
manufacturing companies in Iran, the 1-year prevalence
of self reported LBP was 21% (20% for males and 27%
for females). The prevalence rate of absence due to LBP
was 5% per annum [2]. As part of a World Health
Organization study, LBP was detected in 15.4% of the
population under survey in Tehran (urban area) [3] and
in 23.4% of the population in rural areas in Iran [4].
Specific back pain occurs in approximately 2% of all
patients with back complaints [5]. For the majority of
patients with LBP a specific diagnosis cannot be defined
on the basis of anatomical or physiological abnormal-
ities. Non-specific LBP (NSLBP) is assumed to be in-
flammatory or mechanical in nature [6]. Chronic NSLBP
refers to an episode of activity-limiting LBP (with no
pain referred into either lower limb) that lasts for 3
months or more [7].
Non-pharmacological methods including a variety of
physical agents are the cornerstone of the management
of chronic LBP. Therapeutic ultrasound (US) is among
the commonly used physical modalities for treating soft
tissue injuries [8]. There is a dearth of evidence for the
clinical use of therapeutic US in patients with LBP [9].
Therapeutic US is delivered in two modes: 1) Continu-
ous mode in which the delivery of US is non-stop
throughout the treatment period; 2) Pulsed mode in which
the delivery of US is intermittently interrupted [10].
Therapeutic effects of US are classified as thermal and
non-thermal. Ultrasonic energy causes soft tissue mole-
cules to vibrate from exposure to the acoustic wave. This
increased molecular motion generates frictional heat and
consequently increases tissue temperature. This increased
temperature, named thermal effects, is thought to cause
changes in nerve conduction velocity, increase in enzym-
atic activity, changes in contractile activity of skeletal mus-
cles, increase in collagen tissue extensibility, increase in
local blood flow, increase in pain threshold, and reducing
muscle spasm [11].
Acoustic waves cause normally present minute gas
pockets in the tissue to develop into microscopic bubbles
or cavities. With therapeutic US, stable acoustic cavita-
tion results, whereby the microbubbles pulsate without
imploding. This pulsation leads to microstreaming of
fluid around the pulsating bubbles. When occurring
around cells, this process, referred to as non-thermal
effects, is reported to alter cell membrane activity, vascu-
lar wall permeability, and facilitate soft tissue healing
[12]. Traditionally, continuous US is used for its thermal
effects. Pulsing the US is thought to minimize its thermaleffects [10]. In fact, it is not possible to truly isolate the
thermal and non-thermal effects as both effects occur
with US application [13].
Studies on the efficacy of continuous US in chronic
LBP are lacking [8] and there is little evidence of its ef-
fectiveness in physiotherapy practice [14,15]. However,
lack of evidence is not evidence of lack of effect. There-
fore, the main objective of the current study was to
compare the effect of continuous US to placebo US
combined with exercise therapy on the primary out-
comes, functional status and pain of a group of patients
with NSCLBP, as well as on the secondary outcomes, en-




The protocol of this study was approved by the Research
Council of Rehabilitation Faculty and the Ethical com-
mittee of Tehran University of Medical Sciences
(TUMS). The trial was registered with the Netherlands
Trial Registry (NTR2251). A more detailed description
of the study protocol has been published before [16].
Inclusion criteria in this study were as follows: 1) hav-
ing NSCLBP, 2) age between 18 and 60. Exclusion criteria
were: 1) having nerve root symptoms, 2) having systemic
disease and specific conditions such as neoplasm, frac-
tures, spondylolysthesis, spondylolysis, spinal stenosis,
ankylosing spondylitis, previous low back surgery, 3) tak-
ing medication for specific psychological problems, and
4) being pregnant. Patients were recruited from three
university hospitals of TUMS in Tehran, Iran. Patients
were provided with oral and written information about
the study and were asked to sign a consent form.
Sample size
The primary outcome measure of this study was changes
in functional status using Functional Rating Index (FRI).
Assuming the effect size of .8 for FRI with alpha set
at .05 and a power of .8, and accounting for 10% drop-
outs, the sample size needed was calculated as being 23
patients in each group.
Randomization
Randomization was performed using opaque sealed
envelopes, which were prepared by a statistician using a
computer generated randomization schedule. Half of the
envelopes were allocated to each group ensuring equal
number of subjects in each group.
Interventions
The intervention group received continuous US plus
semi-supervised exercise; the control group received pla-
cebo US plus semi-supervised exercise. Patients were
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vention period and not to participate in any other exer-
cise or treatment program. All patients in both groups
received 10 sessions of treatment, three times a week,
every other day.
US therapy
Recent reviews of therapeutic US have failed to identify
a dose–response relationship [17-19]; though intensities
from 0.5 W/cm2 to 3 W/cm2 have been advocated [18].
Recently published randomized controlled trials, which
have reported significant benefits of therapeutic US over
placebo US, have used intensities of 1 W/cm2 to 1.5
W/cm2 [20,21].
Mild heating in the chronic phase of injury is known
to reduce pain and muscle spasm and to promote heal-
ing process. More chronic lesions are treated with con-
tinuous US. US frequency of 1 MHz is preferable when
treating large and deep soft tissue volumes. Intensities
between .8 to 3 W/cm2 are suggested for chronic lesions
[10,22,23]. Therefore, we chose continuous mode with a
frequency of 1 MHz and an intensity of 1.5 W/cm2 due
to the chronocity of the condition and the deep position
of lower back musculature.
US was applied using Enraf Nonius Sonoplus 434,
ENRAF,Netherland (coupling gel: Sono Gel, Germany).
Slow circular movements were applied using the trans-
ducer head over the painful paravertebral low back re-
gion. The duration of US was estimated for each patient
using Grey’s formula [24]. The average local exposure
time was planned to be one minute and the effective ra-
diating area of the transducer head was 5 cm2. For a pa-
tient with an area of low back pain of 40 cm2, for
example, the required total treatment time was: 1 min ×
(40 cm2/5 cm2) = 8 minutes.
Patients in the intervention group received continuous
US. Placebo US was delivered according to Hashish
et al. [25]. The therapist moved the applicator at the
same rate and pressure as for the continuous US group.
The machine and the light-emitting diode which sig-
naled that its power was connected were in view of the
subject, but the dials which indicated the US were out of
sight. Commonly, the patient is not aware of what she/
he should expect at the beginning of treatment with US
and since even with real US subjects are unaware of any
sensation at most therapeutic intensities [22], patients
were told in both groups that they may feel some heat
and should this cause discomfort, to notify the therapist
in order to safeguard patients in the continuous US
group from overheating.
Exercise therapy
There is strong evidence that exercise is as effective as
other conservative treatments in chronic LBP, andfunctional and pain outcomes significantly improves in
groups receiving exercises relative to other interventions
[26]. Studies indicate that stretching and strengthening
exercises can improve pain and function. Home exer-
cises combined with therapist supervision have been
identified as the most effective strategy for patients with
CLBP [27].
It is recognized that the abdominal muscles, back
extensors, and gluteals are weak in patients with CLBP,
which can cause significant spinal loading. Patients with
LBP also exhibit tightness of hamstring and hip exten-
sors, which may impair spinal mechanics. Therefore,
strengthening and flexibility exercises are important for
a healthy lower back [28].
A semi-supervised exercise program was developed.
The program included posterior pelvic tilts, sit-ups,
bridging, quadruped exercises, and posterior hip and
knee muscles stretching [29,30]. Patients were instructed
to perform 2 to 3 stretches (of all muscles) per day and
hold the stretch for 20 seconds unless it hurts. Strength-
ening exercises started with 5 repetitions and progressed
according to each patient’s improvement, to 3 sets of 10
repetitions. Patients received a pamphlet describing
exercises with figures. To emphasize correct perform-
ance of the exercises at home, all exercises were checked
by the therapist on each treatment session.
Patients were asked to perform the exercises daily; the
stretching exercises before the strengthening exercises.
They were advised to stay active during the day, and
walk for at least 15 minutes before exercising, which
could also act as a warm-up. After completion of all
treatment sessions, patients were asked to maintain the
daily home exercises for one further month. During
the period from the completion of the treatment to the
follow-up measuring session (1 month), patients visited
the clinic once a week to control their exercises for cor-
rect performance.
Outcome measures
Primary and secondary outcome measures were docu-
mented at baseline, after the final treatment session
(after 4 weeks), and at one-month follow-up.
Pain and function are the two most fundamental clin-
ical outcomes for low back pain [31], while accurate as-
sessment of lumbar range of motion has been
recommended as a core domain in the evaluation of
patients with lumbar dysfunction and monitoring treat-
ment progress [32,33]. Since the endurance of trunk
muscles has been shown to be related to the incidence
of low back pain, surface electromyography, specifically
power spectral analysis of EMG signals has become an
increasingly common method for the assessment of lum-
bar muscle activity and localized muscle fatigue and has
been suggested as an objective, safe, easy and non
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back pain [34].
Readers are referred to the design article of this study
for further details on assessment methods related to out-
come measurements [16].
The Primary outcomes were functional disability mea-
sured by the Persian version of the Functional Rating
Index (FRI) [35-37] and pain intensity measured during
last week on a 100 mm visual analogue scale (VAS) [38].
Secondary outcome measures were paravertebral
muscle fatigue during a Biering-Sorensen test using sur-
face electromyography [39], and lumbar flexion and ex-
tension range of motion using the Modified-Modified
Schober Test (MMST) [40].
Briefly, electromyographic data acquisition was per-
formed using an 8-channel surface EMG recorder
(DATA Log Biometrics Ltd) and analyzed by the built in
software, DATA LOG PC software version 7.5 (Biomet-
rics Ltd, UK). The software applied Fast Fourier trans-
formation to calculate median frequency and gave the
rate of decline in median frequency (MF slope) by trend
lines which were calculated using Linear Regression
Analysis based upon the least squares method to pro-
duce a slope m and an intercept of the Y-axis. Preampli-
fied bipolar Ag-AgCl electrodes (Type NO.SX230,
Biometrics Ltd, UK, 10 mm in diameter) with fix center
to center inter electrode distance of 20 mm were used.
The signal was gathered at a sample rate of 1000 Hertz
and a gain of 1000 Decibel.Data analysis
All data were analyzed using SPSS V19, SPSS Inc.,
Chicago, IL, USA. Kolmogorov-smirnov test revealed
normal distribution of data. Repeated measure ANOVA
was used to determine the main and interaction effects
of Time and Group on the outcome measures. Bonfer-
roni test was used for pos -hoc analysis when necessary.
An intention-to-treat analysis of the data was per-
formed to retain data for all patients. In the case of
dropouts, the last recorded values for the outcome mea-
sures were used in the analysis (Last Observation Car-
ried Forward (LOCF)). p-values ≤ .05 were considered as
statistically significant.Results
Figure 1 shows a flow chart of participants. A total of 50
patients were randomized, 25 to each group. One patient
in each group dropped out after the 9th session, because
of personal reasons. Nine more patients (3 patients in
the experimental group and 6 patients in the placebo
group) did not complete the follow-up measurement,
because of travelling, complete improvement or other
personal reasons.Mean age of all participants was 34.7 (SD 12.6) years
with a mean pain history of 7.0 (SD 4.6) years. There
was no statistically significant difference in baseline
characteristics as well as baseline outcome measures be-
tween groups except for endurance time (Table 1). Pos-
sible effect of endurance time at baseline was measured
by evaluating the effect of adding this variable to the
model using analysis of covariance (ANCOVA). It
resulted in no change in the statistical significance of the
Time or Group effects.
Mean values for baseline, after 10 session treatment
and 1-month follow up measurements as well as
P values for baseline differences are shown in Table 2.
As can be seen, FRI has shown improvement (decreased)
in both groups. Also, VAS scores have dropped in both
groups. Details of secondary outcome measures can be
found in Table 2.
Table 3 details the results of the mixed model ANOVA
[Group (US and placebo US) × Time (Pre, Post, and fol-
low-up)] showing the effect of continuous US versus
sham US on outcome measures.
Primary outcome measures
There was a significant effect of Time (p < .001) on FRI.
Bonferroni post-hoc test revealed that FRI scores had
improved significantly after 10 treatment sessions
(p < .001) and over time after one month follow-up in
both groups (p < .001). The improvement of FRI scores
was maintained one month after the end of the 10th
treatment session (p = .24). Main effect of Group on FRI
was significant (p = .004) while the Time × Group inter-
action was not significant (p = .31).
There was a significant effect of Time on VAS
(p < .001). The mixed model ANOVA on VAS did not
reveal a statistically significant Group effect (p = .48).
Post-hoc analysis showed that VAS scores improved sig-
nificantly from baseline to after the 10th session (p < .001)
and continued to improve until the one-month follow-up
measurement (p = .004). The Time × Group interaction
was not significant (p = .48).
Secondary outcome measures
Main effect of Time was not significant on both flexion
(p = .09) and extension lumbar ROM (p = .11). However,
a significant Group effect was identified for flexion
(p = .02) and extension (p = .01). The interaction effect
of Time × Group on lumbar range of motion was not
significant (flexion: p = .23, extension: p = .21).
The values for median frequency slope did not show a
statistically significant Time effect (p > .05); Group effect
(p > .05) or Group × Time interaction (p > .05).
Although main effect of Time on holding time during
Sorensen test was not significant (p = .09), the effect of
Group showed statistical significance (p = .01). There
Assessed for eligibility (n = 56) 
Excluded (n = 6) 
• Not meeting inclusion criteria (n = 4) 
• Declined to participate (n = 0) 
• Other reasons (n = 2) 
Analysed (n = 25)  
• Excluded from analysis (n = 0)
Lost to follow-up (didn’t attend the follow up 
measurement session because of personal reasons 
other than not being satisfied with the treatment) 
(n = 3)
Allocated to continuous US group (n = 25) 
• Received allocated intervention (n = 24)
• Did not receive allocated intervention (n = 1) 
(Discontinued intervention after session 9th 
(travelling))
Lost to follow-up (didn’t attend the follow up 
measurement session because of personal reasons 
other than not being satisfied with the treatment)
(n = 6) 
Allocated to placebo US group (n = 25) 
• Received allocated intervention (n = 24)
• Did not receive allocated intervention (n = 1) 
(Discontinued intervention after session 9th 
(travelling))
Analysed (n = 25)  






Figure 1 Flow diagram of participation and withdrawals for patients in continuous ultrasound and placebo ultrasound groups.
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parameter.
Discussion
In everyday clinical practice the application of US is
often combined with other physiotherapeutical interven-
tions, usually with exercise therapy [41]. The aim of this
study was to investigate whether continuous US can add
to the effects of exercise therapy in patients suffering
from NSCLBP compared to placebo US.
The results showed that both FRI and VAS have
improved after 10 sessions of treatment and over timeTable 1 Characteristics of patients with non specific chronic l





Onset since first episode(years) 5.8 4
BMI** 24.4 4
Sex 25%female _ 75%male
* Ultrasound.
** Body Mass Index.
***p values are for baseline differences between the two groups. Significance levelafter 1 month in both groups. FRI improvement was sig-
nificantly greater in the group receiving continuous US.
This finding is consistent with Ansari et al. [20] who
demonstrated a better functional outcome in a continu-
ous US group in comparison with a placebo US group.
In their study patients did not receive any treatment in
addition to continuous and placebo US. Other rando-
mized trials in which the effect of US is directly com-
pared with placebo US in NSCLBP are lacking. US is
usually studied in comparison with other modalities
[42,43] or is presented in a package of physiotherapy
[44] and is also investigated in other subgroups ofow back pain before treatment in continuous ultrasound
Placebo US P value***
(n=25)
D Mean SD
.3 37.4 11.9 .09
.1 8.1 4.7 .08
.1 25.3 3.5 .39
50%female _ 50%male
≤ .05.
Table 2 Mean and SD of primary and secondary outcome measures for continuous ultrasound and placebo ultrasound
groups at baseline, after 10 treatment sessions, and after 1 month follow up













N=24 N=24 N=21 N=24 N=24 N=18
FRI** 40.8 (14.6) 23.4 (6.9) 22.8 (7.8) 43.9 (16.9) 31.1 (13.4) 30.5 (11.9) .49
VAS** 46.6 (17.7) 26.6 (13.8) 27.7 (14.4) 49 (16) 30.7 (13.1) 25.5 (9.9) .62
Flexion ROM (millimeters) 48.8 (19.4) 52.4 (18.6) 52.4 (19.60) 57.4 (18.9) 59.8 (17.9) 57.5 (18.3) .13
Extension ROM (millimeters) 19.4 (8.2) 20.12 (8.5) 21.7 (8.5) 23.6 (9.6) 24.1 (9.3) 24.7 (9.6) .11
Endurance time(in seconds) 111.5 (33.5) 128.9 (30.2) 128.3 (26.2) 134.2 (27.1) 140.3 (43.5) 139.3 (45.8) .01
Median frequency slope of right muscles
Illiocostalis lumborum -.24 (.17) -.21 (.09) -.19 (.07) -.21 (.13) -.20 (.06) -.19 (.06) .56
Multifidus -.26 (.15) -.26 (.16) -.24 (.13) -.30 (.17) -.25 (.05) -.24 (.05) .82
Gluteus maximus -.11 (.13) -.09 (.10) -.09 (.10) -.13 (.13) -.09 (.09) -.09 (.1) .65
Biceps femoris -.12 (.09) -.12 (.08) -.09 (.06) -.11 (.07) -.12 (.07) -.09 (.05) .83
Median frequency slope of left muscles
Illiocostalis lumborum -.18 (.11) -.18 (.11) -.16 (.09) -.21 (.12) -.19 (.07) -.18 (.08) .29
Multifidus -.24 (.14) -.25 (.15) -.25 (.15) -.29 (.21) -.24 (.10) -.25 (.11) .31
Gluteus Maximus -.06 (.04) -.06 (.06) -.08 (.05) -.09 (.07) -.08 (.05) -.09 (.08) .11
*US: Ultrasound.
**FRI: Functional Rating Index, VAS: Visual Analog Scale.
***p values are for baseline differences between the two groups at significance level ≤ .05.
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lumbar disk herniation [45-47].
Durmus et al. [42] in comparing 3 groups of NSCLBP
patients who received US + exercise, Electrical Stimula-
tion (ES) + exercise and exercise only, showed signifi-
cantly greater improvement in pain and function of the
ES and US groups in comparison with the control group.
The study found no difference in function between
groups receiving either ES, or US but the US group had
significantly better scores regarding pain improvement.
Mohseni et al. [43] compared manipulation and exer-
cise treatment with US and exercise treatment in a ran-
domized clinical trial. One hundred and twenty patients
with chronic LBP were given a program of exercises. In
addition, one group received spinal manipulation ther-
apy and the other group received therapeutic US. Pain
intensity, functional disability, lumbar movements mea-
sured by Modified Modified Schober Test and muscle
endurance were measured shortly before treatment, at
the end of the treatment program and 6 months after
randomization using surface electromyography. Al-
though improvements were recorded in both groups,
patients receiving manipulation/exercise showed a
greater improvement compared with those receiving US/
exercise at both the end of the treatment period and at
6-month follow-up. The authors did not report on the
details of the exercise program, and US delivery was in-
consistent (continuous 1MHz, 1.5-2.5W/cm2 for 5 to 10minutes, average 6 sessions, one or two times a week)
which could both be possible sources of difference with
our study.
Since the current study lacks a third group with no
US, it is impossible to explore the effects of exercise and
US separately except in parts where the continuous US
group has shown significant differences in comparison
to the placebo group. As both groups in our study
improved significantly regarding pain, we can conclude
that the treatment common to both groups (exercise
and mechanical application of US head) have attributed
to the outcome. There is strong evidence that exercise is
an effective treatment in chronic low-back pain [48]. Ex-
ercise programs for CLBP may be designed to reverse
deconditioning or the fear of movement associated with
pain. Such exercises typically include aerobic exercises
like walking as well as strengthening and stretching regi-
mens [27]. The specific exercises administered to
patients in this study may have been of benefit in im-
proving pain. Since many items of the FRI questionnaire
are indirectly related to the pain experienced by patients
during that specific task, the decreased pain achieved
with treatment could have caused the patients in both
groups to perform better during those tasks as well.
However, the individual role of the placebo effects of
US in the placebo group as well as the individual effect
of mechanical movement of US head and exercising in
both groups cannot be specified although each one may
Table 3 Main effects of Time and Group and their
interaction effect on primary and secondary outcome
measures (CI=95%,) *
Outcome measure Effects df F P value
FRI** Time 2 75.92 <.001*
Group 1 3.90 .004*
Time*Group 2 1.03 .31
VAS** Time 2 80.11 <0.001*
Group 1 .00 .48
Time*Group 2 .514 .98
Lumbar flexion Time 2 3.47 .09
Group 1 3.16 .02*
Time*Group 2 1.48 .23
Lumbar extension Time 2 1.53 .11
Group 1 4.12 .03*
Time*Group 2 1.61 .21
Endurance time Time 2 0.63 .43
Group 1 3.05 .05*
Time*Group 2 1.99 .17
Right Illiocostalis Lumborum Time 2 .39 .53
Group 1 .01 .93
Time*Group 2 .52 .41
Right Multifidus Time 2 .06 .16
Group 1 .16 .69
Time*Group 2 .52 .48
Right Gluteus Maximus Time 2 3.41 .73
Group 1 .02 .89
Time*Group 2 .52 .47
Right Biceps Femoris Time 2 5.38 .86
Group 1 .02 .79
Time*Group 2 .05 .82
Left IliocostalisLumborum Time 2 3.65 .06
Group 1 .87 .35
Time*Group 2 .38 .54
Left Multifidus Time 2 1.49 .23
Group 1 .14 .71
Time*Group 2 1.22 .27
Left Gluteus Maximus Time 2 .98 .33
Group 1 .95 .33
Time*Group 2 .86 .36
*The effect of the US versus placebo US on outcome measures was analyzed
using a Group (US and placebo US) × Time (Pre, Post, and follow-up) mixed
model ANOVA at significance level ≤ .05.
**FRI: Functional Rating Index, VAS: Visual Analog Scale.
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US can be the result of moving the applicator head thus
benefitting from the effects of massaging [20,25]. Con-
tinuous movement of the applicator may increase thetemperature of the area under treatment and may stimu-
late the skin receptors causing the pain gate control
mechanism to become active [20]. It has been shown
that moving the applicator of US on the affected area
can change the level of serum cortisol, which in turn can
affect inflammation and swelling [25]. Patients in both
groups could have benefitted from the Placebo effects of
the treatment [49].
A significant difference in the improvement of FRI
scores in favor of the continuous US group can be
related to the thermal and mechanical effects of continu-
ous US.
Morrisette et al. [50] showed that continuous 1 MHz
US given at either 1.5 W/cm2 or 2.0 W/cm2 intensity has
the capability of heating lumbar periarticular tissue while
the intervening muscle may heat as well. Morrisette sta-
ted that the temperature elevation was at a level thought
to be sufficient to produce the theoretical therapeutic
effects proposed with an elevation in temperature.
Regarding secondary outcome measures, although
lumbar flexion and extension ROM increased in both
groups after treatment, the increase did not reach statis-
tical significance within groups. Nevertheless, the
amount of improvement in ROM was significantly
greater in the continuous US group. Durmus et al. [42]
reported significant improvement in Modified Schober
scores in the group receiving US + exercise. However,
this improvement was not significantly different from
the two other treatment groups receiving ES + exercise
and exercise only. In the study carried out by Mohseni
et al. [43], lumbar flexion and extension ROM as mea-
sured by MMST (Modified Modified Schober Test)
improved significantly in US + exercise group but this
improvement was significantly lower in comparison with
the manipulation + exercise group. Though none of the
studies above, had reported the exact exercises pre-
scribed, their difference with our study can be possibly
explained by the differences in exercise type and inten-
sity and patient population as well as the difference in
the dosage of US.
Clinical assessment of movement impairment in low
back pain is predominantly done by measuring changes
in lumbar ROM in order to investigate patient’s response
to treatment [51]. The reduction in pain alongside
stretching and strengthening exercises prescribed could
have contributed to the increase of ROM in both groups.
The significant additional increase of ROM in the con-
tinuous US group may be due to the thermal and mech-
anical effects of continuous US. It has been shown that
temporary increases in range of movement can be pro-
duced by US treatment [52]. There is considerable evi-
dence that the extensibility of collagen based tissues will
change with ultrasound thermal applications as long as
sufficient temperature change is achieved [53]. Since the
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tion is limited to some 3 minutes immediately after
treatment [54], our participants that performed exercises
after the treatment sessions, at home, barely could have
benefited from such thermal effect. Given that patients
suffering from chronic low back pain usually have spasm
[7], using continuous US could have been effective in
decreasing spasm [10] and consequently resulting in
greater ROM increase in comparison with placebo US.
Considering surface EMG parameters, no significant
effect of Time or Group was found on median frequency
slope of all measured muscles.
The assessment of fatigue based on SEMG techniques
during a fatiguing contraction can be demonstrated by a
trend of the power spectrum to lower frequencies usu-
ally measured by the decrease in median frequency. It
has been proposed that better endurance would exhibit
a less precipitous decay rate of the median frequency
[55], though conflicting opinions exist [56]. It has been
indicated that trunk muscle endurance can be increased
by using specific exercises [57].
Sung [58] investigated changes in multifidi muscle en-
durance and functional status after a 4-week supervised
spinal stabilization exercise program in 16 patients pre-
senting with chronic low back dysfunction (LBD).
Results showed that Oswestry scores improved signifi-
cantly from pre to post treatment. Significant pre- to
post treatment increase in multifidi muscle fatigue for
men coupled with a nonsignificant improvement in mul-
tifidi muscle endurance for women was also seen. Sung
[58] concluded that a 4-week spinal stabilization exercise
program significantly improved functional status in
patients presenting with LBD but the program was in-
sufficient to effect muscle fatigue. In another study,
Mohseni et al. [43] did not find any significant change in
median frequency slope or endurance time in the group
of patients with low back pain who received continuous
US plus exercise for an average of 6 sessions. We also
witnessed a nonsignificant change in MF slope of mea-
sured paravertebral muscles, which may imply that the
usefulness and sensitivity of this parameter was limited
in our study.
Regarding endurance time, the group receiving con-
tinuous US showed a significantly greater increase than
the placebo group. Traditionally, endurance is thought
of as the time for sustaining a nonstationary activity,
which ceases with fatigue [59]. One of the main reasons
for muscle fatigue is the accumulation of metabolite
wastes in the region and the inability of the system to
provide adequate blood circulation to supply oxygen to
the tissue and deplete it from wastes [60]. Additionally,
ischemia due to inflammation and spasm is a common
finding in chronic low back pain [7,28,61]. It is possible
that continuous US has improved low back musclefatigue by increasing blood circulation in the region and
helping improve blood supply [17,23,61] which in turn
have caused more sufficient and longer muscle contrac-
tion during the test.
Limitations
The main limitation of this study could be that the treat-
ing physiotherapist who collected the data was not
blinded to the group allocation. The number of dropouts
in our study was higher than what we had predicted at 1
month (22%). The self-reported compliance rate seemed
high, but it was not checked. The study lacks a third
group without US which makes it impossible to com-
ment on individual interventions separately.
Conclusions
This single blind, placebo -controlled, randomized clin-
ical trial showed that adding 1 MHz, 1.5 W/cm2 US to a
semi-supervised regimen of exercise had significantly
beneficial effects on function, lumbar flexion and exten-
sion ROM, and endurance time in patients with
NSCLBP.
Further studies including a third group of no US are
needed to explore the differential effects of each inter-
vention on patients with NSCLBP. In addition, it would
be helpful to measure other surface electromyography
parameters other than median frequency slope, such as
mean frequency, initial median frequency and normal-
ized median frequency slope to explore the possible
effects of the method used in this study on these
parameters.
Studies, in which the methodological shortcomings of
this study and similar studies are addressed, are needed
to verify a dose response relation in patients with
chronic low back pain.
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